Geographic and ethnic variation in Parkinson disease: a population-based study of US Medicare beneficiaries - PubMed (original) (raw)
Comparative Study
Geographic and ethnic variation in Parkinson disease: a population-based study of US Medicare beneficiaries
Allison Wright Willis et al. Neuroepidemiology. 2010.
Abstract
Background: Parkinson disease is a common neurodegenerative disease. The racial, sex, age, and geographic distributions of Parkinson disease in the US are unknown.
Methods: We performed a serial cross-sectional study of US Medicare beneficiaries aged 65 and older from the years 1995, and 2000-2005. Using over 450,000 Parkinson disease cases per year, we calculated Parkinson disease prevalence and annual incidence by race, age, sex, and county. Spatial analysis investigated the geographic distribution of Parkinson disease.
Results: Age-standardized Parkinson disease prevalence (per 100,000) was 2,168.18 (+/-95.64) in White men, but 1,036.41 (+/-86.01) in Blacks, and 1,138.56 (+/-46.47) in Asians. The incidence ratio in Blacks as compared to Whites (0.74; 95% CI = 0.732-0.748) was higher than the prevalence ratio (0.58; 95% CI = 0.575-0.581), whereas the incidence ratio for Asians (0.69; 95% CI = 0.657-0.723) was similar to the prevalence ratio (0.62; 95% CI = 0.617-0.631). Bayesian mapping of Parkinson disease revealed a concentration in the Midwest and Northeast regions. Mean county incidence by quartile ranged from 279 to 3,111, and prevalence from 1,175 to 13,800 (per 100,000). Prevalence and incidence in urban counties were greater than in rural ones (p < 0.01). Cluster analysis supported a nonrandom distribution of both incident and prevalent Parkinson disease cases (p < 0.001).
Conclusions: Parkinson disease is substantially more common in Whites, and is nonrandomly distributed in the Midwest and Northeastern US.
2010 S. Karger AG, Basel.
Figures
Fig. 1
County level age- and race-standardized prevalence (per 100,000) of Parkinson disease among Medicare beneficiaries in the United States (year = 2003).
Fig. 2
County level age- and race-standardized incidence (per 100,000) of Parkinson disease among Medicare beneficiaries in the United States (year = 2003).
Similar articles
- Metal emissions and urban incident Parkinson disease: a community health study of Medicare beneficiaries by using geographic information systems.
Willis AW, Evanoff BA, Lian M, Galarza A, Wegrzyn A, Schootman M, Racette BA. Willis AW, et al. Am J Epidemiol. 2010 Dec 15;172(12):1357-63. doi: 10.1093/aje/kwq303. Epub 2010 Oct 19. Am J Epidemiol. 2010. PMID: 20959505 Free PMC article. - Patterns of Dementia Treatment and Frank Prescribing Errors in Older Adults With Parkinson Disease.
Mantri S, Fullard M, Gray SL, Weintraub D, Hubbard RA, Hennessy S, Willis AW. Mantri S, et al. JAMA Neurol. 2019 Jan 1;76(1):41-49. doi: 10.1001/jamaneurol.2018.2820. JAMA Neurol. 2019. PMID: 30285047 Free PMC article. - Epidemiologic Study of Myasthenia Gravis in the Elderly US Population: A Longitudinal Analysis of the Medicare Claims Database, 2006-2019.
Bruckman D, Lee I, Schold JD, Claytor BR, Silvestri NJ, Hehir MK, Li Y. Bruckman D, et al. Neurology. 2024 Nov 26;103(10):e210005. doi: 10.1212/WNL.0000000000210005. Epub 2024 Nov 4. Neurology. 2024. PMID: 39496108 - Racial/ethnic differences in rates of complex cataract surgery among United States Medicare beneficiaries.
Mahr MA, Hodge DO, Erie JC. Mahr MA, et al. J Cataract Refract Surg. 2018 Feb;44(2):140-143. doi: 10.1016/j.jcrs.2017.10.049. Epub 2018 Mar 7. J Cataract Refract Surg. 2018. PMID: 29525616 - The frequency of idiopathic Parkinson's disease by age, ethnic group, and sex in northern Manhattan, 1988-1993.
Mayeux R, Marder K, Cote LJ, Denaro J, Hemenegildo N, Mejia H, Tang MX, Lantigua R, Wilder D, Gurland B, et al. Mayeux R, et al. Am J Epidemiol. 1995 Oct 15;142(8):820-7. doi: 10.1093/oxfordjournals.aje.a117721. Am J Epidemiol. 1995. PMID: 7572958
Cited by
- Unraveling Parkinson's Disease Neurodegeneration: Does Aging Hold the Clues?
Coleman C, Martin I. Coleman C, et al. J Parkinsons Dis. 2022;12(8):2321-2338. doi: 10.3233/JPD-223363. J Parkinsons Dis. 2022. PMID: 36278358 Free PMC article. Review. - Non-Ergot Dopamine Agonists and the Risk of Heart Failure and Other Adverse Cardiovascular Reactions in Parkinson's Disease.
Crispo JAG, Farhat N, Fortin Y, Perez-Lloret S, Sikora L, Morgan RL, Habash M, Gogna P, Kelly SE, Elliott J, Kohen DE, Bjerre LM, Mattison DR, Hessian RC, Willis AW, Krewski D. Crispo JAG, et al. Brain Sci. 2024 Jul 31;14(8):776. doi: 10.3390/brainsci14080776. Brain Sci. 2024. PMID: 39199470 Free PMC article. Review. - Predictors of survival in patients with Parkinson disease.
Willis AW, Schootman M, Kung N, Evanoff BA, Perlmutter JS, Racette BA. Willis AW, et al. Arch Neurol. 2012 May;69(5):601-7. doi: 10.1001/archneurol.2011.2370. Arch Neurol. 2012. PMID: 22213411 Free PMC article. - Suicidal risk and demoralization in Parkinson disease.
Elfil M, Ahmed N, Alapati A, Bahekar R, Kandil M, Kim C, Schaefer S, Tinaz S, Patel AS, de Figueiredo JM, Louis ED, Koo BB. Elfil M, et al. J Neurol. 2020 Apr;267(4):966-974. doi: 10.1007/s00415-019-09632-2. Epub 2019 Dec 4. J Neurol. 2020. PMID: 31802218 - Prevalence of parkinsonism and Parkinson disease in urban and rural populations from Latin America: A community based study.
Llibre-Guerra JJ, Prina M, Sosa AL, Acosta D, Jimenez-Velazquez IZ, Guerra M, Salas A, Llibre-Guerra JC, Valvuerdi A, Peeters G, Ziegemeier E, Acosta I, Tanner C, Juncos J, Llibre Rodriguez JJ. Llibre-Guerra JJ, et al. Lancet Reg Health Am. 2022 Mar;7:None. doi: 10.1016/j.lana.2021.100136. Lancet Reg Health Am. 2022. PMID: 35300390 Free PMC article.
References
- von Campenhausen S, Bornschein B, Wick R, Botzel K, Sampaio C, Poewe W, Oertel W, Siebert U, Berger K, Dodel R. Prevalence and incidence of Parkinson's disease in Europe. Eur Neuropsychopharmacol. 2005;15:473–490. - PubMed
- Kurtzke JF, Goldberg ID. Parkinsonism death rates by race, sex, and geography. Neurology. 1988;38:1558–1561. - PubMed
- Lanska DJ. The geographic distribution of Parkinson's disease mortality in the United States. J Neurol Sci. 1997;150:63–70. - PubMed
- Lilienfeld DE, Sekkor D, Simpson S, Perl DP, Ehland J, Marsh G, Chan E, Godbold JH, Landrigan PJ. Parkinsonism death rates by race, sex and geography: a 1980s update. Neuroepidemiology. 1990;9:243–247. - PubMed
Publication types
MeSH terms
Grants and funding
- K24 ES017765/ES/NIEHS NIH HHS/United States
- K24ES017765/ES/NIEHS NIH HHS/United States
- R01 ES013743/ES/NIEHS NIH HHS/United States
- T32 NS007205/NS/NINDS NIH HHS/United States
- UL1 TR000448/TR/NCATS NIH HHS/United States
- 5T32NS007205-27/NS/NINDS NIH HHS/United States
- R01ES013743/ES/NIEHS NIH HHS/United States
- UL1RR024992/RR/NCRR NIH HHS/United States
- UL1 RR024992/RR/NCRR NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical